Shares of weight-loss drug developers including Eli Lilly & Co., Novo Nordisk and Structure Therapeutics fell sharply early Wednesday after Roche Holding AG announced early-stage trial data for its experimental obesity pill.
Source link
Trump’s pick to lead the DEA withdraws from consideration
Hillsborough County Sheriff Chad Chronister shares support for Florida Gov Ron DeSantis' announcement of the suspension of Hillsborough County State...